{"id":3992,"date":"2024-11-14T13:46:51","date_gmt":"2024-11-14T13:46:51","guid":{"rendered":"https:\/\/proboostnow.eu\/?page_id=3992"},"modified":"2024-11-14T13:51:44","modified_gmt":"2024-11-14T13:51:44","slug":"proboostthymic-protein-a","status":"publish","type":"page","link":"https:\/\/proboostnow.eu\/en_us\/proboostthymic-protein-a\/","title":{"rendered":"ProBoost\u00aeThymic protein A"},"content":{"rendered":"<p class=\"has-text-align-center\"><strong>ProBoost\u00ae Thymic Protein A<\/strong><\/p>\n<p class=\"has-text-align-center\">Veterin\u00e1rn\u00ed p\u0159\u00edpravek, ur\u010deno pro zv\u00ed\u0159ata<\/p>\n<p>\u00a0 \u00a0 \u00a0 ProBoost obsahuje p\u0159\u00edrodn\u00ed protein produkovan\u00fd epitelem brzl\u00edku, kter\u00fd p\u0159irozen\u011b podporuje imunitn\u00ed syst\u00e9m savc\u016f.<\/p>\n<p><strong>\u00a0 \u00a0 \u00a0 ProBoost \u00ae, Thymic Protein A , je p\u0159\u00edrodn\u00ed purifikovan\u00fd glykoprotein slo\u017een\u00fd zhruba z<\/strong>\u00a0<strong>500 aminokyselin. Tento patentovan\u00fd produkt je vyr\u00e1b\u011bn\u00fd v jedin\u00e9 v\u011bdeck\u00e9 laborato\u0159i na sv\u011bt\u011b v Kalifornii v USA ve steriln\u00edm prost\u0159ed\u00ed v tk\u00e1\u0148ov\u00fdch kultur\u00e1ch z epitelu hov\u011bz\u00edho brzl\u00edku.<\/strong><\/p>\n<p>\u00a0 \u00a0 \u00a0 V organismu je TPA p\u0159irozen\u011b produkov\u00e1n bu\u0148kami brzl\u00edku. B\u011b\u017en\u011b u\u017e\u00edvan\u00e9 metody izolace brzl\u00edkov\u00fdch protein\u016f z telec\u00edch nebo prase\u010d\u00edch brzl\u00edk\u016f vedou k jejich po\u0161kozen\u00ed, fragmentaci a sn\u00ed\u017een\u00ed biologick\u00e9 \u00fa\u010dinnosti a na m\u00edst\u011b je u tohoto zdroje i obava z p\u0159enosu infekc\u00ed, jako je nap\u0159\u00edklad BSE.<\/p>\n<p>\u00a0 \u00a0 \u00a0 P\u0159enesen\u00ed produk\u010dn\u00ed \u010d\u00e1sti brzl\u00edkov\u00e9ho epitelu do tk\u00e1\u0148ov\u00e9 kultury v podob\u011b klon\u016f specifick\u00fdch sekre\u010dn\u00edch bun\u011bk umo\u017enilo z\u00edskat kompletn\u00ed p\u0159\u00edrodn\u00ed neporu\u0161en\u00fd glykoprotein, kter\u00fd m\u00e1 vy\u0161\u0161\u00ed \u00fa\u010dinek na imunitn\u00ed stimulaci, ne\u017e produkty izolovan\u00e9 p\u0159\u00edmo ze zv\u00ed\u0159ec\u00edch brzl\u00edk\u016f nebo izolovan\u00e9 separ\u00e1tn\u011b od kompatibiln\u00edch struktur\u00e1ln\u00edch protein\u016f brzl\u00edkov\u00e9ho epitelu.<\/p>\n<p>\u00a0 \u00a0 \u00a0 Glykoprotein je citliv\u011b purifikov\u00e1n a upraven tak, aby byla zachov\u00e1na jeho biologick\u00e1 \u00fa\u010dinnost. V\u0161echny ostatn\u00ed proteiny, fragmenty nebo l\u00e1tky jsou b\u011bhem \u010di\u0161t\u011bn\u00ed odfiltrov\u00e1ny a z\u016fstane pouze jedin\u00fd brzl\u00edkov\u00fd glykoprotein TPA, kter\u00fd je n\u00e1sledn\u011b lyofilizov\u00e1n a sm\u00edch\u00e1n z d\u016fvodu jeho stabilizace a zachov\u00e1n\u00ed funk\u010dnosti s maltodextrinem.<\/p>\n<p class=\"has-text-align-center\"><strong>Komu je ProBoost\u00ae ur\u010den\u00fd:<\/strong><\/p>\n<p>\u00a0 \u00a0 \u00a0 TPA obsa\u017een\u00fd v ProBoostu je druhov\u011b zcela nebo t\u00e9m\u011b\u0159 identick\u00fd. Je vhodn\u00fd pro v\u0161echny savce.<\/p>\n<p class=\"has-text-align-center\"><strong>Je ProBoost\u00ae l\u00e9k?<\/strong><\/p>\n<p><br \/>\u00a0 \u00a0 \u00a0 ProBoost\u00ae Thymic Protein A nen\u00ed l\u00e9k. TPA je p\u0159\u00edrodn\u00ed p\u0159irozen\u011b se vyskytuj\u00edc\u00ed l\u00e1tka v t\u011ble savc\u016f. ProBoost\u00ae Thymic Protein A obsahuje stejn\u00fd glykoprotein, je\u017e je produkovan\u00fd brzl\u00edkem ka\u017ed\u00e9ho zdrav\u00e9ho organismu, kde p\u0159irozen\u011b stimuluje imunitn\u00ed funkce.<\/p>\n<p class=\"has-text-align-center\"><strong>Kdy je u\u017eite\u010dn\u00e9 u\u017e\u00edv\u00e1n\u00ed ProBoost\u00ae?<\/strong><\/p>\n<p>\u00a0 \u00a0 \u00a0 ProBoost\u00ae Thymic Protein A lze u\u017e\u00edvat v\u017edy, kdy je prosp\u011b\u0161n\u00e9 pos\u00edlit adaptivn\u00ed imunitn\u00ed odpov\u011b\u010f. Nem\u00e1 \u017e\u00e1dn\u00e9 v\u00e1\u017en\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky a m\u016f\u017ee b\u00fdt u\u017e\u00edv\u00e1n soub\u011b\u017en\u011b se v\u0161emi indikovan\u00fdmi l\u00e9\u010divy s v\u00fdjimkou imunosupresiv.<\/p>\n<p class=\"has-text-align-center\">\u2013 1 \u2013<\/p>\n<p class=\"has-text-align-center\"><strong>D\u00c1VKOV\u00c1N\u00cd A ZP\u016eSOB POD\u00c1N\u00cd:<\/strong><\/p>\n<p class=\"has-text-align-center\"><strong>Jak \u010dasto :<\/strong><\/p>\n<p>\u00a0 \u00a0 \u00a0 Je-li\u00a0<strong>ProBoost<\/strong><strong>\u00ae<\/strong>\u00a0pou\u017e\u00edv\u00e1n preventivn\u011b, lze pod\u00e1vat ka\u017ed\u00fd den nebo i jen jednou nebo dvakr\u00e1t t\u00fddn\u011b. Frekvenci lze zv\u00fd\u0161it p\u0159ed obdob\u00edm zv\u00fd\u0161en\u00fdch n\u00e1rok\u016f na imunitn\u00ed syst\u00e9m, b\u011bhem n\u011bj a je\u0161t\u011b n\u011bkolik dn\u00ed po pominut\u00ed obdob\u00ed zv\u00fd\u0161en\u00e9ho rizika.<\/p>\n<p>\u00a0 \u00a0 \u00a0 V p\u0159\u00edpad\u011b podpory imunity b\u011bhem nemoci je doporu\u010deno ka\u017edodenn\u00ed pod\u00e1v\u00e1n\u00ed, denn\u00ed d\u00e1vku je lep\u0161\u00ed rozd\u011blit na n\u011bkolik d\u00edl\u010d\u00edch s odstupem n\u011bkolika hodin, oby\u010dejn\u011b na t\u0159i d\u00e1vky po osmi hodin\u00e1ch.<\/p>\n<p>\u00a0 \u00a0 \u00a0 ProBoost\u00ae Thymic Protein A lze u\u017e\u00edvat dlouhodob\u011b jako podporu norm\u00e1ln\u011b funguj\u00edc\u00edho imunitn\u00edho syst\u00e9mu.<\/p>\n<p class=\"has-text-align-center\"><strong>Zp\u016fsob aplikace:<\/strong><\/p>\n<p>\u00a0 \u00a0 \u00a0 TPA m\u00e1 podobu pr\u00e1\u0161ku a je ur\u010den k or\u00e1ln\u00ed aplikaci. TPA je glykoprotein a podl\u00e9h\u00e1 tud\u00ed\u017e \u010d\u00e1ste\u010dn\u011b destrukci v pr\u016fb\u011bhu tr\u00e1v\u00edc\u00edho procesu. P\u0159i dodr\u017een\u00ed doporu\u010den\u00e9ho d\u00e1vkov\u00e1n\u00ed penetruje dostate\u010dn\u00e9 mno\u017estv\u00ed intaktn\u00edch nepo\u0161kozen\u00fdch molekul do krevn\u00edho ob\u011bhu i kdy\u017e je poz\u0159en spolu s potravou. Vst\u0159eb\u00e1v\u00e1n\u00ed je mo\u017en\u00e9 zlep\u0161it rozpu\u0161t\u011bn\u00edm p\u0159\u00edmo na sliznici \u00fastn\u00ed dutiny. Z\u00e1le\u017e\u00ed na praktick\u00fdch mo\u017enostech pod\u00e1n\u00ed jednotliv\u00fdm druh\u016fm zv\u00ed\u0159at. Ide\u00e1ln\u00ed je rozpu\u0161t\u011bn\u00ed such\u00e9ho pr\u00e1\u0161ku nap\u0159\u00edklad p\u0159\u00edmo pod jazykem, dal\u0161\u00ed mo\u017enost\u00ed je jeho rozpu\u0161t\u011bn\u00ed v n\u011bkolika mililitrech vody nebo ml\u00e9ka u ml\u00e1\u010fat a aplikace po kapk\u00e1ch na vnit\u0159n\u00ed sliznici \u00fastn\u00ed dutiny, ide\u00e1ln\u011b pod jazyk. Pokud nen\u00ed pod\u00e1n\u00ed t\u00edmto zp\u016fsobem mo\u017en\u00e9, lze podat s potravou, nejl\u00e9pe takovou, kterou zv\u00ed\u0159e nehlt\u00e1, ale n\u011bjakou dobu zpracov\u00e1v\u00e1 zuby a jazykem (nasyp\u00e1n\u00ed a prom\u00edsen\u00ed s granulemi, nasyp\u00e1n\u00ed na kousky potravy..), aby se prodlou\u017eil kontakt se sliznicemi dutiny \u00fastn\u00ed.<\/p>\n<p class=\"has-text-align-center\"><strong>D\u00e1vkov\u00e1n\u00ed:<\/strong><\/p>\n<p>\u00a0 \u00a0 \u00a0 D\u00e1vkov\u00e1n\u00ed se \u0159\u00edd\u00ed zejm\u00e9na zdravotn\u00edm stavem zv\u00ed\u0159ete a do ur\u010dit\u00e9 m\u00edry i jeho hmotnost\u00ed a je pouze p\u0159ibli\u017en\u00fdm doporu\u010den\u00edm, kter\u00e9 lze empiricky upravovat tak, aby byl nastolen po\u017eadovan\u00fd efekt.<\/p>\n<p>\u00a0 \u00a0 \u00a0 Pro ko\u010dku nebo st\u0159edn\u011b velk\u00e9ho psa je doporu\u010den\u00e1 z\u00e1kladn\u00ed denn\u00ed d\u00e1vka na podporu imunity b\u011bhem nemoci 2 mcg TPA, co\u017e je p\u0159ibli\u017en\u011b p\u016fl s\u00e1\u010dku. Je vhodn\u00e9 jej\u00ed rozd\u011blen\u00ed alespo\u0148 na dv\u011b, l\u00e9pe t\u0159i d\u00edl\u010d\u00ed d\u00e1vky. P\u0159i dlouhodob\u00e9m pod\u00e1v\u00e1n\u00ed u chronicky oslaben\u00e9ho imunitn\u00edho syst\u00e9mu, jako je tomu nap\u0159\u00edklad u onemocn\u011bn\u00ed FeLV, FIV u ko\u010dek, kter\u00e9 jsou jinak celkov\u011b v dobr\u00e9m zdravotn\u00edm stavu posta\u010d\u00ed 1 mcg TPA. V p\u0159\u00edpad\u011b autoimunitn\u00edch nebo alergick\u00fdch onemocn\u011bn\u00ed m\u016f\u017ee d\u00e1vkov\u00e1n\u00ed kol\u00edsat dle pot\u0159eby vzhledem k aktu\u00e1ln\u00edmu stavu nemoci a environment\u00e1ln\u00edm podm\u00ednk\u00e1m, kter\u00e9 mnohou nap\u0159\u00edklad v\u00fdskytem alergen\u016f vyvolat zhor\u0161en\u00ed symptom\u016f. V ur\u010dit\u00e9m kontextu intenzity vn\u011bj\u0161\u00edch podn\u011bt\u016f nebo aktu\u00e1ln\u00edch projev\u016f nemoci je mo\u017en\u00e9 d\u00e1vkov\u00e1n\u00ed empiricky zvy\u0161ovat na dvoj a\u017e trojn\u00e1sobek a nebo naopak sni\u017eovat.<\/p>\n<p>\u00a0 \u00a0 \u00a0 Stejn\u011b tak lze s d\u00e1vkou pracovat dle aktu\u00e1ln\u00edho zdravotn\u00edho stavu u infek\u010dn\u00edch onemocn\u011bn\u00ed. Akutn\u00ed f\u00e1ze a zah\u00e1jen\u00ed pod\u00e1v\u00e1n\u00ed vy\u017eaduje vy\u0161\u0161\u00ed d\u00e1vkov\u00e1n\u00ed rozd\u011blen\u00e9 alespo\u0148 na 3 aplikace po 8 hodin\u00e1ch. Tato f\u00e1ze trv\u00e1 u akutn\u00ed infekce do \u00fastupu nejz\u00e1va\u017en\u011bj\u0161\u00edch p\u0159\u00edznak\u016f, u chronick\u00fdch infekc\u00ed alespo\u0148 t\u0159i dny, l\u00e9pe t\u00fdden. B\u011bhem rekonvalescence resp. remise m\u016f\u017ee b\u00fdt d\u00e1vka postupn\u011b sni\u017eov\u00e1na.<\/p>\n<p class=\"has-text-align-center\">\u2013 2 \u2013<\/p>\n<p>Orienta\u010dn\u00ed z\u00e1kladn\u00ed d\u00e1vkov\u00e1n\u00ed:<\/p>\n<p>D\u00e1vkov\u00e1n\u00e9 pro zv\u00ed\u0159ata do 1 kg 0,5 \u2013 1mcg TPA\/den.<\/p>\n<p>D\u00e1vkov\u00e1n\u00ed pro zv\u00ed\u0159ata do 50 kg je 2 \u2013 4 mcg TPA\/den<\/p>\n<p>D\u00e1vkov\u00e1n\u00ed pro zv\u00ed\u0159ata od 50 do 100 kg je 4 \u2013 8 mcg TPA\/den<\/p>\n<p>D\u00e1vkov\u00e1n\u00ed pro zv\u00ed\u0159ata vy\u0161\u0161\u00ed hmotnosti nad 100 kg je 4 mcg \/den na ka\u017ed\u00fdch 100 kg<\/p>\n<p class=\"has-text-align-center\"><strong>K<\/strong><strong>ONTRAINDIKACE<\/strong><strong>:\u00a0<\/strong><\/p>\n<p><strong>\u00a0 \u00a0 \u00a0 Je mo\u017en\u00e9 ho pod\u00e1vat soub\u011b\u017en\u011b s l\u00e9\u010divy, nejsou zn\u00e1my \u017e\u00e1dn\u00e9 kontraindikace<\/strong>,\u00a0<strong>jedinou v\u00fdjimkou jsou<\/strong>\u00a0<strong>l\u00e9ky na tlumen\u00ed imunity,\u00a0<\/strong>nap\u0159\u00edklad cyklosporin. Je mo\u017en\u00e9 u\u017e\u00edv\u00e1n\u00ed soub\u011b\u017en\u011b s dal\u0161\u00edmi p\u0159\u00edpravky, kter\u00e9 pozitivn\u011b p\u016fsob\u00ed na imunitn\u00ed syst\u00e9m, jako jsou vitam\u00edny, zinek, imunoglukany atp. Kombinov\u00e1n\u00ed s l\u00e9ky p\u0159\u00edpadn\u011b s dal\u0161\u00edmi p\u0159\u00edpravky na podporu imunity konzultujte s veterin\u00e1rn\u00edm l\u00e9ka\u0159em.<\/p>\n<p class=\"has-text-align-center\"><strong>NE\u017d\u00c1DOUC\u00cd \u00da\u010cINKY:<\/strong><\/p>\n<p>\u00a0 \u00a0 \u00a0 V\u00fdrobce deklaruje, \u017ee v USA bylo prod\u00e1no v\u00edce ne\u017e 16 milion\u016f balen\u00ed a nejsou hl\u00e1\u0161eny \u017e\u00e1dn\u00e9 v\u00e1\u017en\u00e9 ne\u017e\u00e1douc\u00ed ani vedlej\u0161\u00ed \u00fa\u010dinky ani u lid\u00ed ani u zv\u00ed\u0159at. M\u016f\u017ee se vyskytnout lehk\u00e9 podr\u00e1\u017ed\u011bn\u00ed st\u0159ev z d\u016fvodu zv\u00fd\u0161en\u00e9 citlivosti na maltodextrin a Herxheimerova reakce, tj. p\u0159echodn\u011b lehce zv\u00fd\u0161en\u00e1 teplota, bolest kloub\u016f atp. jako reakce organismu na detoxikaci.<\/p>\n<p class=\"has-text-align-center\"><strong>UPOZORN\u011aN\u00cd:<\/strong><\/p>\n<p class=\"has-text-align-center\"><strong>\u00a0V \u017e\u00e1dn\u00e9m p\u0159\u00edpad\u011b neukon\u010dujte v souvislosti s pod\u00e1v\u00e1n\u00edm ProBoost\u00ae Thymic protein A<\/strong><\/p>\n<p class=\"has-text-align-center\"><strong>doporu\u010den\u00fd l\u00e9\u010debn\u00fd postup bez konzultace s veterin\u00e1rn\u00edm l\u00e9ka\u0159em.<\/strong><\/p>\n<p class=\"has-text-align-center\"><strong>ProBoost\u00ae nen\u00ed l\u00e9k, jeho \u00falohou je p\u0159irozen\u00e1 stimulace imunitn\u00edho syst\u00e9mu.<\/strong><\/p>\n<p class=\"has-text-align-center\"><strong>Vysazen\u00ed l\u00e9\u010div p\u0159edepsan\u00fdch veterin\u00e1\u0159em by mohlo v\u00e9st k po\u0161kozen\u00ed zdrav\u00ed pacienta !!!<\/strong><\/p>\n<p>\u00a0 \u00a0 \u00a0 Limituj\u00edc\u00edm faktorem zvy\u0161ov\u00e1n\u00ed d\u00e1vky m\u016f\u017ee b\u00fdt v n\u011bkter\u00fdch p\u0159\u00edpadech mno\u017estv\u00ed maltodextrinu. S\u00e1\u010dek obsahuje krom\u011b \u00fa\u010dinn\u00e9ho proteinu tak\u00e9 0,5 g maltodextrinu. Sacharid maltodextrin je \u0159et\u011bzec molekul gluk\u00f3zy vyr\u00e1b\u011bn\u00fd z \u0161krobu. I kdy\u017e je v potravin\u00e1\u0159stv\u00ed standardn\u011b \u0161iroce pou\u017e\u00edv\u00e1n (v\u00fdroba cukrovinek, hypoalergenn\u00ed diety\u2026.), p\u0159esto upozor\u0148ujeme na mo\u017en\u00e9 probl\u00e9my p\u0159i nadm\u011brn\u00e9 konzumaci, kter\u00e1 se u tohoto produktu v\u0161ak vzhledem k doporu\u010den\u00e9mu d\u00e1vkov\u00e1n\u00ed nep\u0159edpokl\u00e1d\u00e1. Existuje mo\u017enost nav\u00fd\u0161en\u00ed hladiny krevn\u00edho cukru, co\u017e by mohl b\u00fdt probl\u00e9m zejm\u00e9na u diabetik\u016f (obsah maltodextrinu ve v\u0161ech 30 s\u00e1\u010dc\u00edch v jedn\u00e9 krabi\u010dce je 15 gram\u016f, co\u017e hmotnost\u00ed odpov\u00edd\u00e1 zhruba t\u0159em kostk\u00e1m cukru), d\u00e1le m\u016f\u017ee maltodextrin potla\u010dit r\u016fst probiotick\u00fdch kultur a ve v\u011bt\u0161\u00edm mno\u017estv\u00ed ovlivnit st\u0159evn\u00ed mikrofl\u00f3ru.<\/p>\n<p>\u00a0 \u00a0 \u00a0 V EU nen\u00ed maltodextrin za\u0159azen\u00fd mezi alergeny a je i b\u011b\u017enou sou\u010d\u00e1st\u00ed speci\u00e1ln\u00edch veterin\u00e1rn\u00edch hypoalergenn\u00edch diet. P\u0159i intoleranci u citliv\u00fdch jedinc\u016f m\u016f\u017ee vyvolat podr\u00e1\u017ed\u011bn\u00ed st\u0159ev, oby\u010dejn\u011b leh\u010d\u00ed pr\u016fjem. V p\u0159\u00edpad\u011b alergie na maltodextrin je t\u0159eba ProBoost vysadit.<\/p>\n<p>\u00a0 \u00a0 \u00a0 Pokud jsou b\u011bhem pod\u00e1v\u00e1n\u00ed ProBoost\u00ae Thymic Protein A soub\u011b\u017en\u011b pod\u00e1v\u00e1na probiotika, je vhodn\u00e9 dodr\u017eet \u010dasov\u00fd odstup minim\u00e1ln\u011b dv\u011b, l\u00e9pe \u010dty\u0159i hodiny, aby nedo\u0161lo k ne\u017e\u00e1douc\u00ed deregulaci st\u0159evn\u00ed mikrofl\u00f3ry jeho p\u016fsoben\u00edm.<\/p>\n<p class=\"has-text-align-center\">\u2013 3 \u2013<\/p>\n<p>\u00a0 \u00a0 \u00a0 ProBoost\u00ae Thymic Protein A neobsahuje l\u00e1tky, kter\u00e9 jsou pro zv\u00ed\u0159ata, jejich\u017e produkty jsou ur\u010deny k v\u00fd\u017eiv\u011b lid\u00ed, zak\u00e1zan\u00e9 nebo l\u00e1tky farmakologicky \u00fa\u010dinn\u00e9.<\/p>\n<p>\u00a0 \u00a0 \u00a0 ProBoost\u00ae Thymic Protein A neobsahuje omamn\u00e9 a psychotropn\u00ed l\u00e1tky ani patogenn\u00ed mikroorganismy, v\u010detn\u011b patogenn\u00edch pl\u00edsn\u00ed, nebo mikroorganism\u016f podm\u00edn\u011bn\u011b patogenn\u00edch.<\/p>\n<p>\u00a0 \u00a0 \u00a0 Spl\u0148uje po\u017eadavky na bezpe\u010dnost vztahuj\u00edc\u00ed se k p\u016fvodc\u016fm p\u0159enosn\u00fdch spongiformn\u00edch encefalopati\u00ed.<\/p>\n<p>\u00a0 \u00a0 \u00a0 ProBoost\u00ae Thymic Protein A neobsahuje p\u0161enici ani ml\u00e9\u010dn\u00e9 v\u00fdrobky ani \u017e\u00e1dn\u00e9 jin\u00e9 dal\u0161\u00ed potenci\u00e1ln\u00ed alergeny, neobsahuje GMO, maltodextrin je vyr\u00e1b\u011bn\u00fd z kuku\u0159ice.<\/p>\n<p>\u00a0 \u00a0 \u00a0 P\u0159i v\u00fdrob\u011b ProBoost\u00ae Thymic Protein A nen\u00ed ubli\u017eov\u00e1no zv\u00ed\u0159at\u016fm ani \u017e\u00e1dn\u00e1 zv\u00ed\u0159ata neum\u00edraj\u00ed.<\/p>\n<p>\u00a0 \u00a0 \u00a0 Produkt je balen\u00fd v podob\u011b krabi\u010dky, kter\u00e1 obsahuje 30 s\u00e1\u010dk\u016f. Ka\u017ed\u00fd s\u00e1\u010dek obsahuje 500 mg b\u00edl\u00e9ho pr\u00e1\u0161ku, z toho je 4 mcg TPA a ad 500 mg maltodextrinu. Celkov\u00e1 hmotnost krabi\u010dky s t\u0159iceti s\u00e1\u010dky je 66 g, jeden s\u00e1\u010dek v\u010detn\u011b obsahu v\u00e1\u017e\u00ed 2g.<\/p>\n<p>\u00a0 \u00a0 \u00a0 Nepou\u017eit\u00fd veterin\u00e1rn\u00ed p\u0159\u00edpravek ani obaly nevy\u017eaduj\u00ed p\u0159i likvidaci speci\u00e1ln\u00ed opat\u0159en\u00ed.<\/p>\n<p>\u00a0 \u00a0 \u00a0 Datum doporu\u010den\u00e9 spot\u0159eby a v\u00fdrobn\u00ed \u0161ar\u017ee jsou uvedeny na obalu.<\/p>\n<p>\u00a0 \u00a0 \u00a0 Skladov\u00e1n\u00ed p\u0159i pokojov\u00e9 teplot\u011b, chra\u0148te p\u0159ed vysok\u00fdmi teplotami nad 49\u00b0C, skladujte v suchu.<\/p>\n<p>\u00a0 \u00a0 \u00a0 Uchov\u00e1vat mimo dohled a dosah d\u011bt\u00ed.<\/p>\n<p>\u00a0 \u00a0 \u00a0 ProBoost je vyr\u00e1b\u011bn firmou Genicel. Inc. na z\u00e1klad\u011b patent\u016f registrovan\u00fdch v USA : 5616554,7196060 a 7776818 v laboratorn\u00edch podm\u00ednk\u00e1ch od roku 1994 jako prost\u0159edek na podporu adaptivn\u00ed imunity lid\u00ed i zv\u00ed\u0159at.<\/p>\n<p>\u00a0 \u00a0 \u00a0 V\u00fdrobce: Genicel. Inc., 41718 Eastman Dr., Murrieta, CA 92562, USA,\u00a0<a href=\"https:\/\/proboostnow.com\/\">https:\/\/proboostnow.com\/<\/a><\/p>\n<p>\u00a0 \u00a0 \u00a0 Distribuce: Scivetim s.r.o. Br\u00e1zdim, Nov\u00fd Br\u00e1zdim 101, 250 63 , \u010cesk\u00e1 republika.\u00a0I\u010cO: 10973575, DI\u010c: CZ 10973575,\u00a0<a href=\"https:\/\/proboostnow.eu\/en_us\/\">https:\/\/proboostnow.<\/a><a href=\"https:\/\/proboostnow.eu\/en_us\/\">eu<\/a><a href=\"https:\/\/proboostnow.eu\/en_us\/\">\/<\/a>, email:\u00a0<a href=\"mailto:scivetim@seznam.cz\">scivetim@seznam.cz<\/a>, tel: +420 731 218 617<\/p>\n<p>\u00a0 \u00a0 \u00a0 Ne\u017e\u00e1douc\u00ed \u00fa\u010dinky pozorovan\u00e9 na zv\u00ed\u0159atech nebo lidech se hl\u00e1s\u00ed dle \u00a7 4 (\u010c\u00e1stka 64, Sb\u00edrka z\u00e1kon\u016f \u010d. 159 \/ 2021 Strana 1365, VYHL\u00c1\u0160KA ze dne 30. b\u0159ezna 2021 o veterin\u00e1rn\u00edch p\u0159\u00edpravc\u00edch a veterin\u00e1rn\u00edch technick\u00fdch prost\u0159edc\u00edch )<\/p>\n<div class=\"blog-share text-center\">\u00a0<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3992","page","type-page","status-publish","hentry"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/pages\/3992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/comments?post=3992"}],"version-history":[{"count":0,"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/pages\/3992\/revisions"}],"wp:attachment":[{"href":"https:\/\/proboostnow.eu\/en_us\/wp-json\/wp\/v2\/media?parent=3992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}